GLP-1 Marketing Compliance for Med Spas: Ads, Claims, Privacy and Patient Trust

GLP-1 programs have created a significant growth opportunity for med spas, wellness clinics and medical weight-loss practices.

They have also created a more complicated marketing environment.

A GLP-1 campaign may be affected by:

• FDA requirements and enforcement
• FTC advertising standards
• State medical and pharmacy rules
• Provider licensing
• Google Ads policies
• Meta advertising policies
• Patient privacy requirements
• Email, telephone and text-message rules
• Testimonial and endorsement standards
• The products and services being promoted

The exact requirements depend on the clinic’s location, business model, providers, products, advertising channels and the way its program is delivered.

A campaign approved by Google or Meta is not automatically legally compliant. Likewise, a legally supportable claim may still be prohibited by an advertising platform.

This guide provides a practical framework for more responsible GLP-1 marketing. It is general information rather than legal, regulatory or medical advice. Clinics should obtain advice appropriate to their services and jurisdiction.

Why GLP-1 Marketing Requires Additional Care

GLP-1 marketing combines several sensitive areas:

• Prescription medication
• Weight loss
• Personal health
• Medical eligibility
• Patient testimonials
• Potentially compounded products
• Sensitive information collected through forms
• Advertising platforms with healthcare restrictions

A mistake can have consequences beyond a rejected advert.

Potential outcomes include:

• Advertising account restrictions
• Campaign suspension
• Regulatory enquiries
• Warning letters
• Complaints from patients or competitors
• Reputational damage
• Privacy incidents
• Wasted advertising spend
• Misleading prospective patients
• Increased risk for the clinic and its providers

Compliance should therefore influence the strategy from the beginning. It should not be treated as a disclaimer added after the website and adverts have already been created.

Understand the Different Layers of Compliance

GLP-1 marketing is not governed by one universal checklist.

Several layers may apply simultaneously.

Federal Requirements

In the United States, FDA and FTC requirements may affect drug promotion, health claims, testimonials and advertising practices.

State Requirements

State laws and professional rules may affect:

• Medical advertising
• Prescriber licensing
• Telehealth
• Corporate practice of medicine
• Compounding
• Fee advertising
• Provider titles
• Required disclosures

Platform Policies

Google, Meta and other advertising platforms impose their own restrictions.

Privacy Requirements

HIPAA and other federal or state privacy laws may apply to the way information is collected, stored, transmitted and shared.

Communication Rules

Email, telephone and SMS campaigns may be affected by consent, opt-out and telemarketing rules.

Professional Standards

Licensed providers may be subject to board rules governing advertising, professional claims and patient communications.

A clinic should review every layer relevant to its actual model rather than copying a competitor’s campaign.

Begin With an Accurate Description of the Program

The marketing team should understand exactly what the clinic offers before writing any copy.

Document:

• Which providers conduct consultations
• Where those providers are licensed
• Whether consultations are in person or virtual
• How eligibility is assessed
• Which products may be prescribed
• Whether any products are compounded
• Who dispenses or supplies medication
• What ongoing monitoring is included
• What lifestyle or nutritional support is provided
• What happens when someone is not suitable
• What patients pay for
• Whether prices vary
• Which locations provide the service

The website and advertising should accurately reflect this process.

Do not advertise a “doctor-led” program if patients do not interact with a physician. Do not promise ongoing support if the package does not include it. Do not describe a consultation as free if mandatory fees are introduced before it can be completed.

Accuracy begins with the service itself.

Our guide to marketing a GLP-1 weight-loss program at your med spa explains how to position the complete program without reducing the offer to an injection.

Make Only Claims That Can Be Supported

The FTC expects objective health-related claims to be truthful, non-misleading and supported by appropriate evidence.

This applies to express claims and claims implied by the overall advertisement.

A clinic should review statements involving:

• Expected weight loss
• Speed of results
• Safety
• Side effects
• Effectiveness
• Superiority
• Eligibility
• Product equivalence
• FDA status
• Typical patient outcomes
• Emotional or lifestyle benefits
• Long-term results

The FTC’s Health Products Compliance Guidance explains how health claims are assessed and the importance of appropriate substantiation.

Express Claims

These are claims stated directly.

Examples include:

• “Patients lose 20% of their body weight.”
• “This program is completely safe.”
• “Guaranteed weight loss.”
• “Works better than every other treatment.”

Implied Claims

These are messages a reasonable consumer may take from the overall advert even when they are not stated directly.

An image of rapid physical transformation beside the words “Start today” may imply a typical or expected outcome.

A disclaimer may not correct an otherwise misleading overall impression.

Review:

• Headlines
• Body copy
• Images
• Captions
• Testimonials
• Charts
• Footnotes
• Calls to action
• The relationship between them

Avoid Guaranteed and Absolute Language

Words such as these require particular caution:

• Guaranteed
• Risk-free
• Completely safe
• Permanent
• Effortless
• Instant
• Works for everyone
• No side effects
• Clinically proven
• Best
• Superior
• FDA approved

Some may be supportable in a narrowly defined context, but they should never be used casually.

A consultation-led message is usually more accurate:

Request a consultation to discuss your goals, medical history and potential options with a qualified provider.

This does not promise eligibility, treatment or a particular result.

Do Not Guarantee Clinical Eligibility

A lead form or booking request should not tell someone that they qualify for GLP-1 treatment.

Suitability should be determined through the clinic’s approved clinical process.

Avoid statements such as:

• “You qualify.”
• “You are approved.”
• “Get prescribed today.”
• “Everyone is eligible.”
• “Complete this quiz for guaranteed treatment.”
• “Start medication immediately.”

Safer administrative language may include:

• Request an eligibility assessment
• Book an initial consultation
• Speak with a qualified provider
• Learn about potential options
• Check consultation availability
• Begin the assessment process

Marketing automation can help arrange an appointment. It should not replace the provider’s clinical judgment.

Clearly Distinguish Approved and Compounded Products

The distinction between FDA-approved and compounded drugs is particularly important.

The FDA states that compounded drugs are not FDA-approved. It does not review compounded products for safety, effectiveness or quality before they are marketed in the same manner as approved drugs.

The FDA has warned businesses against making claims that compounded GLP-1 products are:

• FDA-approved
• Generic versions of approved drugs
• The same as approved drugs
• Clinically proven to produce the same results
• Sourced from an “FDA-approved pharmacy”
• Sourced from an “FDA-licensed pharmacy” when that description suggests FDA approval

The FDA’s current guidance on promoting compounded drugs explains these concerns.

In March 2026, the FDA announced warning letters to 30 telehealth companies over false or misleading claims involving compounded GLP-1 products.

Clinics should review:

• The exact product being offered
• How it is described
• Which company compounded it
• Product and pharmacy imagery
• Comparisons with approved drugs
• Claims based on studies of a different product
• References to FDA status
• Landing-page FAQs
• Email and SMS copy
• Provider scripts

Do not assume that a small “compounded” label corrects a page that otherwise presents the product as equivalent to an approved drug.

Be Precise When Marketing Semaglutide

“Semaglutide” may refer to different products and contexts.

The clinic’s marketing should not blur distinctions between:

• FDA-approved branded products
• A compounded product
• The broader active ingredient
• Different approved indications
• General GLP-1 weight-management programs

Avoid using research about one product as automatic evidence for claims about another.

The product, indication, formulation, patient population and context matter.

Our guide to semaglutide marketing for med spas explains how to position a clinic program around consultation, clinical oversight and support rather than relying entirely on medication claims.

Review Testimonials and Before-and-After Content

Patient stories can be powerful, but they can also communicate objective claims.

A testimonial saying, “I lost 45 pounds in three months,” may be understood as evidence of what other patients can expect.

The FTC states that endorsements claiming specific results are generally interpreted as representing what others can expect. A statement such as “results not typical” or “individual results may vary” may not be enough on its own.

Advertisers generally need either:

• Adequate support that the result is typical; or
• A clear and conspicuous disclosure of the generally expected result in the circumstances shown

Review the FTC’s guidance on endorsements and expected results before publishing outcome-focused testimonials.

Clinics should also confirm:

• The testimonial is genuine
• The patient has given appropriate written permission
• The wording has not been changed misleadingly
• Any material connection is disclosed
• The experience relates to the actual service being promoted
• The presentation does not imply a guaranteed outcome
• Patient privacy is protected
• State professional rules permit the format

Before-and-after images need similar scrutiny.

Consider:

• Whether both images depict the same person
• Whether lighting, pose and clothing are comparable
• Whether the timeframe is accurate
• Whether retouching or filters were used
• Whether the result is representative
• Whether other interventions contributed
• Whether the platform permits the imagery
• Whether consent covers advertising use

A consent form does not make a misleading claim acceptable.

Do Not Purchase, Fabricate or Manipulate Reviews

Reviews should reflect genuine patient experiences.

Avoid:

• Purchasing reviews
• Creating fake patient accounts
• Having staff pose as patients
• Offering rewards only for positive feedback
• Suppressing negative reviews improperly
• Rewriting a patient’s review to make it more promotional
• Asking patients to make claims they did not independently choose to make
• Using a reviewer’s private medical details in a public response

The FTC’s Consumer Reviews and Testimonials Rule prohibits several deceptive practices involving reviews and testimonials.

A responsible reputation management process for med spas should make it easy for genuine patients to provide honest feedback without pressure.

Follow Google’s Healthcare Advertising Policies

Google restricts healthcare advertising, prescription-drug services and prescription-drug terminology.

Its policies can affect:

• Keywords
• Advert copy
• Landing pages
• Geographic targeting
• Online prescribing
• Telemedicine
• Pharmacies
• Medication dispensing
• Personalized advertising
• Certification

Google’s current policy states that prescription-drug terms may be used for promotional purposes in the United States, Canada and New Zealand, subject to local requirements.

Certification may still be required to target restricted drug terms as keywords or for particular business models, including some telemedicine and online pharmacy services.

Rules differ by country. Some locations prohibit prescription-drug terminology in promotional ads or landing pages except for specific eligible businesses.

Before launching, review:

• The clinic’s business model
• Countries and states targeted
• Provider licensing
• Keywords
• Advert copy
• Landing-page terminology
• Whether medication can be ordered online
• Whether certification is required
• Current Google policy updates

Google’s Healthcare and Medicines policy should be checked directly before every launch.

Our guide to GLP-1 advertising for med spas provides a more detailed Google and Meta campaign framework.

Follow Meta’s Health and Wellness Rules

Meta treats weight-loss advertising as a restricted category.

Its current policy states that ads promoting weight-loss products or services must target people aged 18 or older.

Meta also restricts content that asserts or implies personal attributes.

Avoid language such as:

• “Are you obese?”
• “You need to lose weight.”
• “Your body is unhealthy.”
• “We know you have struggled with your weight.”
• “Are you ashamed of how you look?”
• “Your medical condition makes weight loss impossible.”

This wording implies that the advertiser knows sensitive information about the person seeing the advert.

A more appropriate approach is to describe the service:

• “Explore our medically supervised weight-management program.”
• “Request a consultation with our clinical team.”
• “Learn about personalized weight-management support.”
• “Discover the consultation process at our clinic.”

Before publishing, check Meta’s current Health and Wellness advertising policy.

Advert approval is not permanent. Policies and enforcement can change, and previously accepted creative may later be restricted.

Be Careful With Audience Targeting

Health and prescription-drug information can be treated as sensitive.

Avoid building audiences from information that reveals or strongly implies:

• A medical condition
• Prescription-drug use
• Treatment eligibility
• A specific diagnosis
• Sensitive health behavior

Do not upload patient lists to advertising platforms without confirming that doing so is legally permitted, appropriately disclosed and consistent with platform policies.

Particular care is required with:

• Customer-list audiences
• Lookalike audiences
• Retargeting
• Website-visitor audiences
• App activity
• Quiz responses
• Treatment-page visitors
• Prescription-related search behavior

A standard marketing consent checkbox may not authorize every downstream use of health-related information.

Have the clinic’s privacy and advertising advisers review audience creation and data sharing.

Protect Information Collected Through Lead Forms

GLP-1 lead forms may collect information that is sensitive even before someone becomes a patient.

Review:

• What information is requested
• Why it is needed
• Where it is stored
• Who can access it
• Which vendors receive it
• How it is transmitted
• How long it is retained
• Whether the user has consented
• Whether the form is part of a regulated clinical process
• Whether privacy notices accurately describe the use

A general marketing form may only need:

• Name
• Telephone number
• Email address
• Preferred contact method
• General appointment preference
• Consent to be contacted

Do not collect a detailed medical history through an ordinary advertising form simply because it might help qualify the lead.

Sensitive clinical information should be collected through an appropriately designed, secure and approved process.

Our guide to GLP-1 lead generation for med spas explains how to capture useful enquiries without asking the marketing form to perform a clinical assessment.

Audit Pixels and Tracking Technologies

Healthcare websites commonly use:

• Google Analytics
• Google Ads tags
• Meta Pixel
• Call tracking
• Session recording
• Heatmaps
• Chat widgets
• Embedded calendars
• Form software
• CRM integrations

These tools can transmit URLs, device data, identifiers, form activity and other information to third parties.

The clinic should map:

• Every tracking tool
• Every page on which it loads
• What information it collects
• Which vendor receives the information
• Whether it loads before consent
• Whether it appears on appointment or patient-portal pages
• Whether business associate or other contractual requirements apply
• Whether the privacy notice accurately describes it

HHS has published guidance concerning online tracking technologies used by HIPAA-regulated entities.

The legal treatment of particular data and pages can depend heavily on the facts. Clinics should obtain current privacy advice rather than assuming that a common marketing tool is automatically safe.

Separate Marketing Pages From Clinical Systems

Where possible, create a clear distinction between:

• Public educational content
• Marketing enquiry forms
• Consultation booking
• Clinical intake
• Patient portals
• Medical records
• Prescribing systems

Each stage can involve different data and access requirements.

For example:

1. A public page explains the program.
2. A basic form requests contact information.
3. The clinic helps arrange a consultation.
4. An approved clinical system collects medical history.
5. Qualified providers conduct the assessment.

This structure is easier to explain and govern than a single marketing quiz that attempts to collect everything immediately.

Obtain Appropriate Communication Consent

GLP-1 campaigns often use:

• Telephone calls
• SMS
• Email
• Automated reminders
• Nurture sequences
• Reactivation campaigns
• AI-assisted conversations

The rules can vary according to:

• The communication channel
• Whether the message is marketing or operational
• Whether automation is involved
• The relationship with the recipient
• The wording of the consent
• State law
• Federal telemarketing requirements

Consent language should be:

• Clear
• Visible
• Specific
• Recorded
• Appropriate to the intended communication
• Easy to withdraw

Commercial emails should comply with applicable requirements, including accurate sender information and functioning opt-out mechanisms. The FTC provides a CAN-SPAM compliance guide.

Telephone and SMS campaigns may also trigger FCC, TCPA, Do Not Call and state requirements.

Do not purchase a generic lead list and assume the individuals consented to receive GLP-1 marketing from your clinic.

Use AI as Administrative Support, Not a Clinician

AI can assist with:

• Immediate enquiry acknowledgement
• General process information
• Appointment availability
• Booking guidance
• Reminders
• Basic administrative questions
• Routing messages to staff
• Nurturing opted-in leads

It should not independently:

• Diagnose
• Prescribe
• Recommend medication
• Confirm eligibility
• Minimize risks
• Interpret symptoms
• Change a treatment plan
• Make emergency decisions
• Invent clinical answers

Create clear escalation rules.

The system should transfer a conversation to qualified staff when someone asks an individualized medical question or reports a health concern.

Keep the AI knowledge base current and limit it to approved information.

A properly governed med-spa CRM automation system should support the clinic team without pretending to replace professional care.

Apply Compliance Standards to SEO Content

Organic content is still marketing.

A page does not avoid advertising and consumer-protection concerns simply because it was created for SEO rather than paid promotion.

Review:

• Titles
• Meta descriptions
• Headings
• Featured images
• Provider biographies
• FAQs
• Calls to action
• Testimonials
• Schema markup
• Internal links
• Claims in downloadable guides

Do not publish unsupported claims merely because they appear in a blog article.

Medical content should include:

• Clear authorship
• Qualified review where appropriate
• Accurate sources
• Publication and review dates
• Balanced explanations
• A distinction between general information and personal advice
• A process for correcting outdated material

Our guide to GLP-1 SEO for med spas explains how to build useful search visibility without relying on thin or exaggerated content.

Review Influencer and Affiliate Relationships

If the clinic works with influencers, affiliates, referral partners or paid ambassadors, material relationships should be disclosed clearly.

A material connection could include:

• Payment
• Free treatment
• Discounted treatment
• Commission
• Gifts
• Complimentary membership
• Referral fees
• Any other benefit affecting credibility

Disclosures should be difficult to miss and understandable to an ordinary viewer.

Do not rely on:

• A disclosure hidden in a profile
• A vague hashtag
• A disclosure placed after a long caption
• Verbal disclosure that is hard to hear
• A platform tool without checking how it appears

Influencers should only make claims the clinic could lawfully and appropriately make itself.

The FTC’s social media disclosure guidance provides practical examples.

Create a Formal Content-Approval Process

A documented review process reduces the chance that an unapproved claim reaches the public.

A practical workflow may include:

1. The marketing team drafts the asset.
2. A clinical reviewer checks medical accuracy.
3. A compliance or legal reviewer checks claims and disclosures.
4. The marketing team makes revisions.
5. The final version receives documented approval.
6. The approved asset and evidence are stored.
7. A review date is scheduled.
8. Later edits go through the same process.

The process should cover:

• Website pages
• Blog posts
• Google Ads
• Meta Ads
• Social posts
• Videos
• Testimonials
• Email sequences
• SMS templates
• AI scripts
• Downloadable guides
• Provider talking points
• Third-party promotions

Do not allow staff to modify approved health claims casually because they want an advert to sound stronger.

Maintain a Claims Evidence File

For each meaningful health or outcome claim, record:

• The exact wording
• Where it appears
• The evidence supporting it
• The product or service to which the evidence relates
• The date reviewed
• The reviewer
• Limitations
• Required disclosures
• The scheduled review date

Evidence about one approved product should not automatically be used to promote a different compounded product.

Similarly, evidence from a controlled study may not support the outcome implied by a dramatic patient testimonial.

A claims file makes future reviews faster and helps ensure that approved language remains consistent across channels.

Lower-Risk and Higher-Risk Marketing Language

No phrase is automatically compliant in every context. However, some approaches generally require more scrutiny than others.

The complete advert matters—not only one sentence.

Images, testimonials, headlines and omissions can change the overall meaning.

Pre-Launch GLP-1 Marketing Checklist

Before publishing a campaign, confirm:

Program

• The service description is accurate.
• Provider roles are stated correctly.
• Licensing and service locations have been checked.
• The consultation process is explained.
• The marketing does not guarantee eligibility.

Products and Claims

• The exact product is identified accurately.
• Approved and compounded products are not blurred.
• Health and outcome claims have support.
• Compounded products are not described as FDA-approved or generic.
• Claims based on another product have not been reused improperly.

Advertising Platforms

• Google’s current healthcare policy has been checked.
• Meta’s current health and wellness policy has been checked.
• Age and geographic targeting are appropriate.
• Required certifications have been confirmed.
• Personal-attribute language has been removed.

Testimonials and Creative

• Testimonials are genuine.
• Appropriate permission has been obtained.
• Expected results and atypical outcomes have been assessed.
• Material connections are disclosed.
• Images are authentic and not misleading.
• Before-and-after content has been reviewed.

Privacy and Tracking

• Form fields are limited to what is needed.
• Privacy notices are accurate.
• Pixels and analytics tools have been audited.
• Vendors and integrations have been reviewed.
• Sensitive information is routed through an appropriate system.
• Access is restricted to authorized people.

Follow-Up

• Consent language matches the planned communication.
• Email and SMS opt-outs work.
• AI scripts are limited to approved administrative functions.
• Clinical questions are escalated.
• Message frequency is reasonable.
• Reactivation audiences are permitted to be contacted.

Approval

• Clinical review is complete.
• Legal or compliance review is complete where required.
• Final approval is documented.
• Evidence supporting claims has been stored.
• A future review date has been set.

Monitor Campaigns After Launch

Compliance is not a one-time event.

After launch:

• Review search terms
• Monitor advert comments
• Check lead quality
• Confirm forms are working
• Audit automated conversations
• Review landing-page changes
• Monitor policy disapprovals
• Check whether staff follow approved scripts
• Review complaints
• Recheck consent and opt-out handling
• Update content when products or guidance change
• Revisit platform policies regularly

A campaign can become inaccurate even if it was correct when first published.

Products, providers, pricing, regulations and platform policies change.

What to Do After an Advertising Disapproval

Do not repeatedly resubmit the same campaign without understanding the reason.

Instead:

1. Read the cited policy.
2. Review the advert and landing page together.
3. Check medication terminology.
4. Check the targeted locations.
5. Confirm certification requirements.
6. Review images and implied claims.
7. Check other pages linked from the destination.
8. Correct the underlying issue.
9. Document the revision.
10. Appeal only when there is a reasonable basis.

Repeated attempts to evade a restriction can create greater account risk.

Changing a single word may not help if the overall website still promotes a restricted or misleading service.

What to Do After Receiving a Regulatory Complaint

Treat a regulatory letter, legal notice or formal complaint seriously.

Preserve:

• The published content
• Earlier versions
• Approval records
• Supporting evidence
• Campaign settings
• Communications
• Vendor records
• Consent records
• Relevant contracts
• Dates of publication and removal

Do not destroy records or make speculative admissions.

Pause affected marketing where appropriate and obtain advice from a qualified professional familiar with the relevant regulatory area.

Common GLP-1 Compliance Mistakes

Copying a Competitor

A competing clinic may be violating platform rules or legal requirements.

Treating Ad Approval as Legal Approval

Advertising platforms do not provide legal clearance.

Relying on a Disclaimer

A disclaimer may not correct a misleading headline, testimonial or overall impression.

Calling Compounded Drugs Generic

Compounded products are not FDA-approved generics.

Using Research About a Different Product

Evidence must support the actual claim and product being promoted.

Letting AI Write Unreviewed Medical Copy

AI-generated content may invent evidence, omit limitations or confuse products.

Collecting Too Much Information

Marketing forms should not become unsecured medical intake systems.

Installing Tracking Pixels Everywhere

Appointment, intake and patient-portal pages require particular privacy consideration.

Using Aggressive Weight-Loss Creative

Shame-based messages, extreme results and personal-attribute language create risk.

Ignoring Organic Content

SEO articles and social posts still communicate claims to consumers.

Failing to Recheck Old Pages

Outdated claims can remain indexed and visible long after a campaign ends.

Responsible Marketing Builds a Stronger Clinic

Compliance should not be viewed only as a restriction.

Clear, accurate marketing can improve:

• Patient trust
• Lead quality
• Provider credibility
• Consultation expectations
• Advertising stability
• Long-term reputation
• Conversion rates
• Patient retention

A prospective patient should understand:

• What the clinic offers
• Who provides the service
• That an assessment is required
• That outcomes vary
• What support is included
• How to take the next step

That clarity helps the clinic attract people looking for a credible medical weight-management program rather than an unrealistic promise.

Work With a GLP-1 Marketing Agency

At Med Spa Marketing Guys, we help med spas and medical weight-loss practices build structured GLP-1 patient-acquisition systems.

Depending on the clinic, this can include:

• GLP-1 marketing strategy
• SEO
• Google Ads
• Facebook and Instagram Ads
• Landing pages
• CRM implementation
• Lead tracking
• Email and SMS follow-up
• Consultation booking
• Review generation
• Patient reactivation
• Campaign reporting

Our marketing processes are designed around clear, consultation-led messaging and practical patient journeys.

Clinical, legal and regulatory decisions remain with the clinic and its qualified advisers.

Learn more about our GLP-1 marketing services or request a strategy call to discuss your current system.

Frequently Asked Questions

Can Med Spas Advertise GLP-1 Programs?

Med spas may be able to advertise GLP-1 and medical weight-loss programs, depending on their location, licensing, business model, products and advertising platform.

The clinic should review applicable legal requirements and current platform policies before launching.

Can a Clinic Advertise Semaglutide?

The answer depends on the product, context, jurisdiction, platform and clinic model.

Advertising should clearly and accurately describe the actual service and should not blur the distinction between approved and compounded products.

Can Compounded Semaglutide Be Called Generic?

No. The FDA states that compounded drugs are not FDA-approved generic drugs.

Clinics should not describe a compounded product as a generic version of an approved drug or imply that it is identical.

Can a Med Spa Say Its Compounding Pharmacy Is FDA-Approved?

The FDA states that it does not approve or license compounding pharmacies or outsourcing facilities in the way this phrase implies.

Avoid describing a facility as an “FDA-approved pharmacy.”

Are “Results May Vary” Disclaimers Enough?

Not necessarily.

The FTC states that phrases such as “results not typical” or “individual results may vary” may not correct the message communicated by a specific-results testimonial.

Can Med Spas Use Before-and-After GLP-1 Photos?

Potentially, but consent alone is not sufficient.

The clinic should consider typicality, accuracy, timeframe, other interventions, image manipulation, privacy, platform policies and applicable professional rules.

Can GLP-1 Ads Run on Facebook and Instagram?

Meta permits some weight-loss advertising to adults, subject to its health and wellness standards.

Campaigns should avoid personal-attribute language, misleading outcomes and prohibited targeting practices.

Can GLP-1 Ads Run on Google?

Google restricts prescription-drug terminology and services involving online prescribing, dispensing and medication sales.

What is permitted depends on the targeted location, advertiser type, terminology and certification status.

Does HIPAA Apply to GLP-1 Lead Forms?

It depends on the clinic, form, information collected, context and entities involved.

Even when HIPAA does not apply to a particular interaction, other privacy, consumer-protection and state laws may still be relevant.

Can AI Qualify GLP-1 Leads?

AI can help collect administrative information and guide prospects towards booking.

It should not diagnose, prescribe, recommend treatment or confirm medical eligibility.

Do GLP-1 Marketing Emails Need an Unsubscribe Option?

Commercial emails must follow applicable email-marketing requirements, including CAN-SPAM where relevant.

Clinics should provide clear opt-out options and honor requests promptly.

Who Should Review GLP-1 Marketing Content?

Depending on the asset, review may involve marketing, clinical, legal, regulatory, privacy and information-security professionals.

High-risk product and outcome claims should not be approved solely by the person writing the advert.